Inventor · disambiguated record
André Frenzel
Also filed as: FRENZEL ANDRE · FRENZEL ANDRÉ
1 granted patent·8 pending applications·0 citations·filing 2019–2024
14Inventor score
Files withAMUNIX PHARMACEUTICALS INC6CORAT THERAPEUTICS GMBH1FUSION PHARMACEUTICALS INC1IOMX THERAPEUTICS AG1
Top patents by PatentIndex Score
9 records- 0177US12215156B2HER-2 targeted bispecific compositions and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2023·Granted Feb 4, 2025·0 cites·8 claims
- 0264US2024400696A1Compositions targeting epidermal growth factor receptor and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0362US2023322922A1Her-2 targeted bispecific compositions and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0451US2021054077A1Cd3 antigen binding fragments and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0551US2023121775A1Cd3 antigen binding fragments and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0644US2023312729A1Egfr antigen binding fragments and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0744US2025002576A1Claudin 18.2-binding antibodies and fragments thereofFUSION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0841US2024059758A1Therapeutic antibodies with neutralizing activity against sars-cov-2 glycoprotein sCORAT THERAPEUTICS GMBH·Filed 2021·Application pending·0 cites
- 0932US2021061908A1Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance against anti-tumour immune responses, and uses thereofIOMX THERAPEUTICS AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when André Frenzel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →